Parkinson's disease or Parkinson's diseases?

Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study.

Neuropsychologia·2000

Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG).

European journal of human genetics : EJHG·1999

Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.

Neurology·1999

Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum.

The Journal of comparative neurology·1999

[Genetics of Parkinson disease].

La Revue de medecine interne·1999

Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.

Archives of neurology·1999

Genetic analysis of inflammatory proteins following BCG vaccination in Danish children.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Phlorizin attenuates chronic kidney disease induced bone loss by mitigating sclerostin mediated inhibition of Wnt/β-catenin signaling and ameliorating metabolic alterations.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Frankenia hirsuta-derived biofunctionalized ZnO nanoparticles attenuate inflammation-associated tissue injury: Integrated pharmacological evaluation supported by network pharmacology and molecular docking.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

From gut-derived metabolites to topical targets: 5-(3',4'-dihydroxyphenyl)-γ-valerolactone as an anti-inflammatory candidate for skin and mucosal inflammation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Glutathione in redox homeostasis: Bridging molecular mechanisms, bioavailability constraints, and translational challenges in systemic therapeutics.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

MHY5535, a novel PPARα antagonist, sensitizes ovarian cancer stem cells to chemotherapy by disrupting fatty acid oxidation-dependent mitochondrial metabolism.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Frontiers in chemistry·2026

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Movement disorders clinical practice·2026

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

The New Zealand medical journal·2026

Researchers struggle to improve nonopioid pain drugs.

Science (New York, N.Y.)·2026

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Pulmonary circulation·2026

Psychoactive and Neurobiological Effects of Ketamine in Humans: A Scoping Review of Clinical Evidence.

Journal of clinical medicine·2026

Related Experiment Videos

Parkinson's disease or Parkinson's diseases?

Related Concept Videos

Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study.

Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG).

Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France.

Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum.

[Genetics of Parkinson disease].

Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.

Genetic analysis of inflammatory proteins following BCG vaccination in Danish children.

Phlorizin attenuates chronic kidney disease induced bone loss by mitigating sclerostin mediated inhibition of Wnt/β-catenin signaling and ameliorating metabolic alterations.

Frankenia hirsuta-derived biofunctionalized ZnO nanoparticles attenuate inflammation-associated tissue injury: Integrated pharmacological evaluation supported by network pharmacology and molecular docking.

From gut-derived metabolites to topical targets: 5-(3',4'-dihydroxyphenyl)-γ-valerolactone as an anti-inflammatory candidate for skin and mucosal inflammation.

Glutathione in redox homeostasis: Bridging molecular mechanisms, bioavailability constraints, and translational challenges in systemic therapeutics.

MHY5535, a novel PPARα antagonist, sensitizes ovarian cancer stem cells to chemotherapy by disrupting fatty acid oxidation-dependent mitochondrial metabolism.

Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond.

Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.

Prescribing and monitoring of riluzole in amyotrophic lateral sclerosis: a retrospective cohort study from Health New Zealand - Te Whatu Ora Waitaha Canterbury.

Researchers struggle to improve nonopioid pain drugs.

Patterns and Trends in Vasoactive Medication Use in Patients With Pulmonary Arterial Hypertension Presenting With Shock.

Psychoactive and Neurobiological Effects of Ketamine in Humans: A Scoping Review of Clinical Evidence.

Related Experiment Videos

Parkinson's disease or Parkinson's diseases?

Related Concept Videos

Related Articles